Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POT1 antisense RNA 1 (POT1-AS1, LOC101928283) is a long non-coding RNA located near the POT1 gene, transcribed in the antisense direction. It does not encode a protein but is implicated in the regulation of gene expression at the RNA level. Recent studies suggest POT1-AS1 inhibits epithelial-mesenchymal transition (EMT), marking it as a potential regulator in cancer progression and metastasis, particularly in gastric carcinoma and possibly other cancers. However, its mechanistic details, druggability, and biomarker roles are not well elucidated in current literature[6]. It is not a receptor, enzyme, transporter, or conventional therapeutic target, and no interacting drugs or safety concerns specific to POT1-AS1 have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POT1 antisense RNA 1 (POT1-AS1).